Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Colby who wrote (7093)	4/15/1998 6:50:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

To all, CNBC just did a piece on Viagra. The following was reported: 1)Inquiries have been overwhelming. 2)Pfizer views the ED market as "essentially untapped". 3)Pfizer plans to spend over $35,000,0000 just to advertise to the consumer. 4)They said Pfizer has an excellent reputation for marketing. At this point institutions might start seriously accumulating vivus stock. The over reaction is absurd.

To: Colby who wrote (7093)	4/15/1998 6:54:00 PM
From: Herm	Respond to of 23519

Colby, VVUS has been a thrill everyday since I've owned it! What a viper of a stock. I've made some heavy premies by writing covered calls on this sucker. That helps offset some of the give back (paper loss). Now, why would Zack's Research up the recommendation on April 11, 1998 from a "hold" to "moderate buy?" That is the second upgrade. At one point in Feb. they had a "sell!" The MMs are jerking us around folks. They don't want to kill VVUS since they can reverse the price and milk the mother up, down, and sideways!